Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-21

Clinical Trial Update: CyberKnife for Unresectable Renal Tumors [NA]

View source ↗

Summary

A completed clinical trial evaluating CyberKnife radiosurgery for unresectable renal tumors (kidney cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Renal Cancer | NA | Status: COMPLETED